In conclusion, we have successfully applied standard Huisgen
1,3-dipolar cycloaddition conditions to the synthesis of the
triazolobenzoxazepine and triazolobenzoxazocine ring systems.
Attempts to utilize the chemistry developed for the synthesis of the
isoindolotriazole rings gave low yields and therefore a re-evaluation
of the standard was employed to good success. Investigation into
the reaction conditions revealed the trimethylsilyl group to be a rate
limiting culprit. Interestingly, although the use of silicon as a
directing group normally favors the desired 1,5 regioisomer, in the
case of these two analogs, the reaction simply failed to progress in a
reasonable timeframe. Further investigation into the reaction
conditions demonstrated that in situ deprotection and subsequent
cyclization could be achieved with cesium fluoride in DMF, and
microwave heating, all within thirty minutes. NMR characterization
confirmed formation of the assigned 1,5-isomers completing the
first published synthesis of the triazolobenzoxazepine and
triazolobenzoxazocine systems.
[5] S. Coats, J. Link, D. Gauthier, and D. Hlasta, Organic Letters,
2005, 7, 1469-1472.
[6] M. Alajarin, J. Cabrera, A. Pastor, J. M. Villalgordo,
Tetrahedron. Lett., 2007, 3495-3499.
[7] V. Rostovtsev, L. Green, V. Fokin, K. B. Sharpless, Angew.
Chem. Int. Ed. 2002, 41, p. 2596-2599.
[8] H. Yamakoshi, N. Kanoh, C. Kudo, A. Sato, K. Ueda, M.
Muroi, S. Kon, M. Satake, H. Ohori, C. Ishioka, Y. Oshima,
H. Osada, N. Chiba, H. Shibata, and Y. Iwabuchi, ACS Med.
Chem. Lett., 2010, 1, 273-276.
[9] M. Khan, M. Alam, M. Rashid, R. Chowdhury, Bioorg. Med.
Chem. 2005, 13, 4796-4805.
[10] B. C. Boren, S. Narayan, L. K. Rasmussen, L. Zhang, H.
Zhao, Z. Lin, G. Jia, V. V. Fokin, J. Am. Chem. Soc., 2008,
130, 8923-8930.
[11] B. C. Boren, S. Narayan, L. K. Rasmussen, L. Zhang, H.
Zhao, Z. Lin, G. Jia, V. V. Fokin, J. Am. Chem. Soc., 2008,
130, 8923-893.
Table 1. Various reaction conditions optimizing 8 to 1 and 2.
Ring
System
(n)
Solvent
Additive
Temp
(oC)
LCMS[d]
%
Conversion
0
1
0
0
1
1
0
0
0
1
Toluene
Toluene
Toluene
Toluene
Toluene
Toluene
Toluene
Toluene/DMF
DMF
---
---
115
115
100
100
115
115
100
100
180
180 [c]
23%
19%
20%
30%
21%
17%
0%
CuI
Ru[a]
CuI
Ru[a]
CsF
CsF
CsF
CsF
100%[b]
61%
87%
DMF
[a] Chloro(cyclopentadienyl)bis(triphenylphosphine)ruthenium (II)
[b] Complete conversion to desilylated intermediate with less 10%
product after 4 hours. [c] microwave irradiation, 30 minutes. [d]
Liquid chromatography – mass spectroscopy.
[1] a) M. J. Genin, D. A. Allwine, D. J. Anderson, M. R.
Barbachyn, D. E. Emmert, S. A. Garmon, D. R. Graber, K. C.
Grega, J. B. Hester, D. K. Hutchinson, J. Morris, R. J.
Reischer, C. W. Ford, G. E. Zurenko, J. C. Hamel, R. D.
Schaadt, D. Stapert, and B. H. Yagi J. Med. Chem. ,2000 , 43,
953; b) A. K. Mandadapu, S. K. Sharma, S. Gupta, D. G. V.
Krishna, and B. Kundu. Org. Lett. 2011, 13 (12), 3162–3165;
c) F. Suzuki, T. Kuroda, T. Kawakita, H. Manabe, S.
Kitamura, K. Ohmori, M. Ichimura, H. Kase, S. Ichikawa J.
Med. Chem. 1992, 35 (26), 4866–4874; d) M. Yamada, S.
Hamamoto, K. Hayashi, K. Takaoka, H. Matsukura, M.
Yotsuji, K. Yonezawa, K. Ojima, T. Takamatsu, K. Taya, H.
Yamamoto, T. Kiyoto, H. Kotsubo, PCT Int. Appl., WO
9921849, 1999; e) R. Alvarez, S. Velazquez, F. San, S.
Aquaro, C. De-Clercq, C. Perno, A. Karlsson, J. Balzarini, M.
J. Camarasa, J. Med. Chem. 1994, 37, 4185–4194; f) M. G.
Bell, R. A. Doti, M. S. Dowling, M. J. Genin, P. A. Lander, T.
Ma, N. B. Mantlo, J. M. Ochoada, L. S. Stelzer, R. E. Stites,
A. M. Warshawsky, US 8106077, 2012.
[2] a) R. Huisgen, Pure Appl. Chem., 1989, 61, 613; b) R.
Huisgen, In 1,3-Dipolar Cycloaddition chemistry, A. Padwa,
Ed., Wiley, New York, NY, 1984, pp. 1-176.
[3] C. Chowdhury, S. Mandal, B. Achari, Tetrahedron Lett., 2005,
46, 8531-8534.
[4] Yamakoshi et al, ACS Med. Chem. Lett., 2010 , 1, 273-276.
3